PVTX-321 (Compound 16a) is an orally active estrogen receptor alpha (ERalpha) degrader. PVTX-321 can potently degrade ERalpha (DC50=0.15 nM in MCF-7 cells) and also has inhibitory activity against mutant ERalpha (IC50=59 nM). PVTX-321 is promising for research of ER+/HER2- breast cancer[1].
Molekulargewicht:
839.00
CAS Nummer:
[3026004-38-3]
Formel:
C51H55FN4O6
Target-Kategorie:
Estrogen Receptor/ERR
Anwendungsbeschreibung:
MCE Product type: Reference compound1
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten